During the past decade, Praxis und Tagesklinik für Onkologie und Hämatologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis und Tagesklinik für Onkologie und Hämatologie" #1 collaborator was "Roche Pharma AG" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Praxis und Tagesklinik für Onkologie und Hämatologie" are "Breast Cancer" (2 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials) and "HER 2 Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Praxis und Tagesklinik für Onkologie und Hämatologie" in a lesser frequency.

Most popular intervention types in "Praxis und Tagesklinik für Onkologie und Hämatologie" are "Drug" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Capecitabine + bevacizumab OR Paclitaxel +/- bevacizumab" (1 trials), "Pertuzumab" (1 trials), "Ribociclib and aromatase inhibitor or fulvestrant" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxis und Tagesklinik für Onkologie und Hämatologie" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Praxis und Tagesklinik für Onkologie und Hämatologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Praxis und Tagesklinik für Onkologie und Hämatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis und Tagesklinik für Onkologie und Hämatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".